.

august 2, 2017.-related side effects. its manufacturer, eli lilly, plans to submit a new drug application to the fda in the second half of 2018..
.
.. to add a comment. registration is free, and takes less than a minute..: "fremanezumab for the preventive treatment of chronic migraine.".